Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Cosmetic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Melasma: an Up-to-Date Comprehensive Review.Dermatol Ther (Heidelb). 2017; 7: 305-318
- Pattern and prevalence of physiological cutaneous changes in pregnancy: A study of 2000 antenatal women.Indian J Dermatol Venereol Leprol. 2011; 77: 409-411
- Update on Melasma—Part I: Pathogenesis.Dermatol Ther (Heidelb). 2022; https://doi.org/10.1007/s13555-022-00779-x
- Melasma: Trends in worldwide Internet searches (2000-2019).Indian J Dermatol Venereol Leprol. 2022; 88: 675-677
- Psychological disturbances in patients with pigmentary disorders: a cross-sectional study.J Eur Acad Dermatol Venereol. 2020; 34: 392-399
- Depression, anxiety, and self-esteem in women with facial melasma: an Internet-based survey in Brazil.Int J Dermatol. 2021; 60: e346-e347
- Therapeutic Insights in Melasma and Hyperpigmentation Management.J Drugs Dermatol. 2019; 18: 718-729
- Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.Am J Dermatopathol. 2005; 27: 96-101
- Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.Indian J Dermatol Venereol Leprol. 2019; 85: 367-373
- Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.Clin Exp Dermatol. 2008; 33: 305-308
- Dermal Pathology in Melasma: An Update Review.Clin Cosmet Investig Dermatol. 2022; 15: 11-19
- The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence.Dermatol Surg. 2020; 46: 1642-1650
- Endothelial cells promote pigmentation through endothelin Receptor B activation.J Invest Dermatol. 2015; 135: 3096-3104
- UV induces VEGF through a TNF-alpha independent pathway.FASEB J. 2003; 17: 446-448
- Effect of tranexamic acid on melasma: A clinical trial with histological evaluation.J Eur Acad Dermatol Venereol. 2013; 27: 1035-1039
- Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women.J Eur Acad Dermatol Venereol. 2013; 27: 151-156
- A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma.J Eur Acad Dermatol Venereol. 2009; 23: 1254-1262
- Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma.J Invest Dermatol. 2011; 131: 1692-1700
- Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction.J Dermatol Sci. 2011; 64: 223-228
- Melanin transfer in human skin cells is mediated by filopodia - A model for homotypic and heterotypic lysosome-related organelle transfer.FASEB J. 2010; 24: 3756-3769
- Skin pigmentation and its control: From ultraviolet radiation to stem cells.Exp Dermatol. 2021; 30: 560-571
- The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity.Int J Mol Sci. 2022; 23: 1-33
- Chinese women with melasma exhibit a low minimal erythema dose to both UVA and UVB.Photodermatol Photoimmunol Photomed. 2022; 38: 38-43
- Synergistic effects of long-wavelength ultraviolet A1 and visible light on pigmentation and erythema.Br J Dermatol. 2018; 178: 1173-1180
- Role of estrogen, progesterone and prolactin in the etiopathogenesis of melasma in females.J Pakistan Assoc Dermatologists. 2011; 21: 241-247
- Aggravating factors for melasma: A prospective study in 197 Tunisian patients.J Eur Acad Dermatol Venereol. 2010; 24: 1060-1069
- The biological actions of estrogens on skin.Exp Dermatol. 2002; 11: 487-502
- Hormonal milieu in the maintenance of melasma in fertile women.J Dermatol. 1998; 25: 510-512
- Melasma: How hormones can modulate skin pigmentation.J Cosmet Dermatol. 2019; 18: 458-463
- Fibroblast morphology, growth rate and gene expression in facial melasma.An Bras Dermatol. 2022; 97: 575-582
- Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.Int J Cosmet Sci. 2014; 37: 222-228
- H19 RNA downregulation stimulated melanogenesis in melasma.Pigment Cell Melanoma Res. 2009; 23: 84-92
- How hormones may modulate human skin pigmentation in melasma: An in vitro perspective.Exp Dermatol. 2019; 28: 709-718
- PDZK1 upregulation in estrogen-related hyperpigmentation in Melasma.J Invest Dermatol. 2012; 132: 2622-2631
- Risk factors for facial melasma in women: A case-control study.Br J Dermatol. 2014; 171: 588-594
- Melasma improving spontaneously upon switching from a combined oral contraceptive to a hormone-releasing intrauterine device: A report of four cases.Acta Derm Venereol. 2015; 95: 624-625
- Clinical and epidemiologic features of melasma: a multicentric cross-sectional study from India.Int J Dermatol. 2019; 58: 1305-1310
- Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients.Postep Dermatologii i Alergol. 2015; 32: 327-330
- Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: A prospective randomized comparative trial.J Am Acad Dermatol. 2015; 72 (e1): 189-190
- Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens.J Am Acad Dermatol. 2021; 84: 1393-1397
- High-SPF sunscreens (SPF ≥ 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts.J Am Acad Dermatol. 2012; 67: 1220-1227
- Sunscreen Application, Safety, and Sun Protection: The Evidence.J Cutan Med Surg. 2019; 23: 357-369
- Sunscreen recommendations for patients with skin of color in the popular press and in the dermatology clinic.Int J Women’s Dermatol. 2021; 7: 165-170
- Sun protection use behaviour among university students from 25 low, middle income and emerging economy countries.Asian Pac J Cancer Prev. 2015; 16: 1385-1389
- Photoprotection J Am Acad Dermatol. 2005; 52: 937-958
- Melasma: Update on management.Semin Cutan Med Surg. 2018; 37: 217-225
- Analysis of the effects of hydroquinone and arbutin on the differentiation of melanocytes.Biol Pharm Bull. 2013; 36: 1722-1730
- A New Formula for Depigmenting Human Skin.Arch Dermatol. 1975; 111: 40-48
- A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.Br J Dermatol. 2008; 159: 697-703
- A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.J Cosmet Dermatol. 2007; 6: 36-39
- Preventing melasma recurrence: Prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.J Eur Acad Dermatol Venereol. 2012; 26: 611-618
- Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.J Am Acad Dermatol. 2010; 62: 962-967
- New oral and topical approaches for the treatment of melasma.Int J Women’s Dermatol. 2019; 5: 30-36
- Hydroquinone: myths and reality.Clin Exp Dermatol. 2021; 46: 636-640
- Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.J Cosmet Dermatol. 2019; 18: 870-873
- Cysteamine cream as a new skin depigmenting product.J Am Acad Dermatol. 2013; 68: AB189
- Inhibition of melanin synthesis by cystamine in human melanoma cells.J Invest Dermatol. 2000; 114: 21-27
- Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review.J Cosmet Dermatol. 2021; 20: 3593-3602
- Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman’s formula in subjects with epidermal melasma: A randomized, double-blind clinical trial study.Ski Res Technol. 2021; 27: 24-31
- Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman’s formula.J Cosmet Dermatol. 2019; 18: 293-295
- Azelaic acid: Evidence-based update on mechanism of action and clinical application.J Drugs Dermatol. 2015; 14: 964-968
- Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma.Acta Dermato-venereologica, Suppl. 1989; 69: 58-61
- The Treatment of Melasma 20% Azelaic Acid versus 4% Hydroquinone Cream.Int J Dermatol. 1991; 30: 893-895
- Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.J Cosmet Dermatol. 2011; 10: 282-287
- Comparison of efficacy of products containing azelaic acid in melasma treatment.J Cosmet Dermatol. 2016; 15: 269-282
- Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents.Dermatology. 2002; 205: 329-339
- Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes.J Invest Dermatol. 2004; 122: 1338-1341
- The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.J Cosmet Dermatol. 2020; 19: 167-172
- Methimazole in the treatment of melasma: A clinical and dermascopic study.J Clin Aesthet Dermatol. 2021; 14: 14-20
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.Nature. 2013; 494: 256-260
- Inhibition of melanogenesis by the antidiabetic metformin.J Invest Dermatol. 2014; 134: 2589-2597
- A molecular perspective on the potential benefits of metformin for the treatment of inflammatory skin disorders.Int J Mol Sci. 2020; 21: 1-13
- Topical metformin in the treatment of melasma: A preliminary clinical trial.J Cosmet Dermatol. 2020; 19: 1161-1164
- Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman’s formula) in treating melasma: A randomized controlled study.J Cosmet Dermatol. 2022; 21: 2508-2515
- Efficacy and Safety of Topical Therapy With Botanical Products for Melasma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Front Med. 2022; 8: 3074
- A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among filipinos.Int J Dermatol. 2014; 53: 1412-1416
- Tranexamic acid inhibits angiogenesis and melanogenesis in vitro by targeting VEGF receptors.Int J Med Sci. 2020; 17: 903-911
- Efficacy and safety of tranexamic acid in melasma: A meta-analysis and systematic review.Acta Derm Venereol. 2017; 97: 776-781
- Topical tranexamic acid as a promising treatment for melasma.J Res Med Sci. 2014; 19: 753-757
- Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.J Cosmet Dermatol. 2015; 14: 174-177
- Therapeutic Effects of Topical Tranexamic Acid in Comparison with Hydroquinone in Treatment of Women with Melasma.Dermatol Ther (Heidelb). 2017; 7: 417-424
- Tranexamic acid for adults with melasma: A systematic review and meta-analysis.Biomed Res Int. 2018; : 1-13
- Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.J Am Acad Dermatol. 2018; 78: 363-369
- Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study.J Eur Acad Dermatol Venereol. 2020; 34: 2636-2644
- Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis.J Am Acad Dermatol. 2016; 75: 385-392
- Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum.Pharm Res. 2013; 30: 1099-1109
- Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies.Curr Drug Deliv. 2019; 16: 444-460
- Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.J Am Acad Dermatol. 2022; 86: 797-810
- Radiofrequency Microneedling: A Comprehensive and Critical Review.Dermatol Surg. 2021; 47: 755-761
- Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study.Dermatol Ther (Heidelb). 2022; 12: 1325-1336
- A face-split study to evaluate the effects of microneedle radiofrequency with Q-switched Nd:YAG laser for the treatment of melasma.Ann Dermatol. 2019; 31: 133-138
- Combined treatment of melasma involving low-fluence Q-switched Nd:YAG laser and fractional microneedling radiofrequency.J Dermatolog Treat. 2018; 30: 352-356
- Safety and efficacy of mesotherapy in the treatment of melasma: A review article.J Cosmet Dermatol. 2022; 21: 118-129
- Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.Clin Exp Dermatol. 2017; 42: 728-734
- The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma—A randomized clinical trial.Dermatol Ther. 2021; 34e14924
- A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.Indian J Dermatol Venereol Leprol. 2019; 85: 39-43
- Comparative study of localised intradermal microinjection of tranexamic acid and oral tranexamic acid for the treatment of melasma.Int J Res Dermatol. 2018; 4: 363
- Comparative Study between the Efficacy of Intradermal Injection and Oral Administration of Tranexamic Acid in Treatment of Melasma.Benha J Appl Sci. 2020; 5: 1-5
- A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma.J Cutan Aesthet Surg. 2013; 6: 139
- The Efficacy of Intralesional Tranexamic Acid in the Treatment of Melasma in Iraqi Patients.IRAQI Postgrad Med J. 2020; 19
- Platelet-rich plasma is a promising therapy for melasma.J Cosmet Dermatol. 2021; 20: 2431-2436
- Transforming growth factor-β1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.Int J Biochem Cell Biol. 2004; 36: 1482-1491
- Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis.Dermatol Ther (Heidelb). 2021; 11: 1587-1597
- Selective removal of stratum corneum by microdermabrasion to increase skin permeability.Eur J Pharm Sci. 2009; 38: 95-103
- Microdermabrasion assisted delivery of glycolic acid 70% peel for the treatment of melasma in dark-skinned patients.Dermatol Ther. 2021; 34e15025
- Dermabrasion: A curative treatment for melasma.Aesthet Plast Surg. 2001; 25: 114-117
- Chemical peels in melasma: A review with consensus recommendations by Indian pigmentary expert group.Indian J Dermatol. 2017; 62: 470-476
- Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: A systematic review and meta-analysis of comparative trials.J Cosmet Dermatol. 2020; 19: 2812-2819
- Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation.Science. 1983; 220: 524-527
- Laser therapy in the treatment of melasma: a systematic review and meta-analysis.Lasers Med Sci. 2022; 37: 2099-2110
- Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.Skin Ther Lett. 2016; 21: 1-7
- Complications of carbon dioxide laser resurfacing: An evaluation of 500 patients.Dermatol Surg. 1998; 24: 315-320
- The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium:Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians: Prospective, Randomized, and Split-Face Comparative Study.Dermatol Surg. 2017; 43: 1120-1133
- The efficacy of energy-based devices combination therapy for melasma.Dermatol Ther. 2021; 34e14927
- A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis.J Electron Microsc (Tokyo). 2011; 60: 11-18
- Clinical and histopathologic assessment of facial melasma after low-fluence q-switched neodymium-doped yttrium aluminium garnet laser.Dermatol Surg. 2016; 42: 507-512
- Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?.J Cosmet Dermatol. 2016; 15: 420-426
- Low-fluence q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.Dermatol Surg. 2010; 36: 76-87
- The Asian Problem of Frequent Laser Toning for Melasma.J Clin Aesthet Dermatol. 2017; 10: 40
- Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.J Eur Acad Dermatol Venereol. 2015; 29: 1339-1346
- Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: A prospective, randomized, controlled trial.Dermatol Surg. 2014; 40: 842-850
- Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.Lasers Med Sci. 2016; 31: 1657-1663
- A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations.Lasers Surg Med. 2021; 53: 9-49
- A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians.Lasers Surg Med. 2021; 53: 95-103
- Efficacy and safety of a novel picosecond laser using combination of 1064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.Lasers Surg Med. 2017; 49: 899-907
- Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.J Cosmet Laser Ther. 2018; 20: 134-139
- Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal Injury.Lasers Surg Med. 2004; 34: 426-438
- Fractional photothermolysis: A novel aesthetic laser surgery modality.Dermatol Surg. 2007; 33: 525-534
- Laser-induced transepidermal elimination of dermal content by fractional photothermolysis.J Biomed Opt. 2006; 11041115
- Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study.J Am Acad Dermatol. 2011; 64: 516-523
- Treatment of melasma in Asian skin using a fractional 1,550-nm laser: An open clinical study.Dermatol Surg. 2009; 35: 1499-1504
- Treatment of Melasma using fractional photothermolysis: A report of eight cases with long-term follow-up.Dermatol Surg. 2010; 36: 1273-1280
- Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.J Cosmet Dermatol. 2020; 19: 1284-1289
- Side effects and complications of fractional laser photothermolysis: Experience with 961 treatments.Dermatol Surg. 2008; 34: 301-307
- Non-ablative 1,550nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled split-face study.Lasers Surg Med. 2010; 42: 607-612
- Lasers in melasma: A review with consensus recommendations by Indian pigmentary expert group.Indian J Dermatol. 2017; 62: 477-482
- The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians.Lasers Surg Med. 2007; 39: 381-385
- Treatment of melasma with the 1,927-nm fractional thulium fiber laser: A retrospective analysis of 20 cases with long-term follow-up.Lasers Surg Med. 2013; 45: 95-101
- Evaluation of a low energy, low density, non-ablative fractional 1927nm wavelength laser for facial skin resurfacing.J Drugs Dermatol. 2015; 14: 1262-1267
- A review of laser and light therapy in melasma.Int J Women’s Dermatol. 2017; 3: 11-20
- A review of melasma treatment focusing on laser and light devices.Semin Cutan Med Surg. 2016; 35: 223-232
- Treatment of melasma with the 1,927-nm fractional thulium fiber laser: A retrospective analysis of 20 cases with long-term follow-up.Lasers Surg Med. 2013; 45: 95-101
- A retrospective study of the management of Chinese melasma patients using a 1927 nm fractional thulium fiber laser.J Cosmet Laser Ther. 2013; 15: 200-206
- Efficacy and safety of 1927 nm fractional Thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients.J Cosmet Laser Ther. 2019; 21: 408-411
- 1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting Recommendations.Dermatol Surg. 2022; 48: 195-200
- The safety and efficacy of treatment with a 1,927-nm diode laser with and without topical hydroquinone for facial hyperpigmentation and melasma in darker skin types.Dermatol Surg. 2018; 44: 1304-1310
- The 1440 nm and 1927 nm Nonablative Fractional Diode Laser: Current Trends and Future Directions.J Drugs Dermatol. 2020; 19: s3-s11
- Melasma treatment with pulsed-dye laser and triple combination cream: A prospective, randomized, single-blind, split-face study.Arch Dermatol. 2011; 147: 1106-1108
- Copper bromide laser vs triple-combination cream for the treatment of melasma: A randomized clinical trial.JAMA Dermatol. 2015; 151: 791-792
- Therapeutic outcome of melasma treatment by dual-wavelength (511 and 578 nm) laser in patients with skin phototypes III-V.Clin Exp Dermatol. 2014; 39: 292-297
- Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status.J Am Acad Dermatol. 2016; 74: 981-1004
- Laser-assisted drug delivery.Dermatol Surg. 2016; 42: 919-931
- Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk.Eur J Pharm Sci. 2016; 92: 1-10
- Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.Clin Cosmet Investig Dermatol. 2018; 11: 13-20
- The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.Lasers Med Sci. 2020; 35: 2015-2021
- Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser.J Cosmet Dermatol. 2021; 20: 105-109
- A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma.Clin Exp Dermatol. 2011; 36: 864-870
- Melasma: a comprehensive update: part I.J Am Acad Dermatol. 2011; 65: 689-697
- Melasma treatment: a systematic review.J Dermatolog Treat. 2022; 33: 1816-1837
- Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.PLoS One. 2022; 17
- Development and validation of a health-related quality of life instrument for women with melasma.Br J Dermatol. 2003; 149: 572-577
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
